Novel IRE1-dependent proinflammatory signaling controls tumor infiltration by myeloid cells

Joanna Obacz(Immodulon Therapeutics (United Kingdom)), Éric Chevet(Inserm)
bioRxiv (Cold Spring Harbor Laboratory)
January 29, 2019
Cited by 7


Related Papers